Bayer said its eye treatment aflibercept showed positive results in a late-stage trial, including improved vision gains for people suffering from some retinal diseases.
Related Posts
Walmart Earnings: Holiday Shopping Is Off to a Strong Start
The retailer said its sales rose in the latest quarter, helped by strong demand for toys and other goods.
Uber Shares Jump as Company Returns to Profitability
Second-quarter results beat expectations, and the company projected sales growth.
How Booming Electricity Demand Is Stalling Efforts to Retire Coal and Gas
Companies are redoing the math behind the green-energy transition amid the rise of AI data centers.